-
1
-
-
84876533570
-
Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis
-
Racey, C.S., Withrow, D.R., Gesink, D., Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can. J. Public Health 104:March (2013), e159–e166.
-
(2013)
Can. J. Public Health
, vol.104
, Issue.March
, pp. e159-e166
-
-
Racey, C.S.1
Withrow, D.R.2
Gesink, D.3
-
2
-
-
84943665685
-
Reaching women who do not participate in the regular cervical cancer screening program by offering self-sampling kits: a systematic review and meta-analysis of randomised trials
-
Verdoodt, F., Jentschke, M., Hillemanns, P., Racey, C.S., Snijders, P.J.F., Arbyn, M., Reaching women who do not participate in the regular cervical cancer screening program by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur. J. Cancer 51 (2015), 2375–2385.
-
(2015)
Eur. J. Cancer
, vol.51
, pp. 2375-2385
-
-
Verdoodt, F.1
Jentschke, M.2
Hillemanns, P.3
Racey, C.S.4
Snijders, P.J.F.5
Arbyn, M.6
-
3
-
-
84941762237
-
When is it effective to offer self-sampling to non-attendees-response
-
Rozemeijer, K., de Kok, I.M., Naber, S.K., et al. When is it effective to offer self-sampling to non-attendees-response. Cancer Epidemiol. Biomarkers Prev., 24(August), 2015, 1296.
-
(2015)
Cancer Epidemiol. Biomarkers Prev.
, vol.24
, Issue.August
, pp. 1296
-
-
Rozemeijer, K.1
de Kok, I.M.2
Naber, S.K.3
-
4
-
-
84938585776
-
Offering self-sampling to non-attendees of organized primary HPV screening: When do harms outweigh the benefits?
-
Rozemeijer, K., de Kok, I.M., Naber, S.K., et al. Offering self-sampling to non-attendees of organized primary HPV screening: When do harms outweigh the benefits?. Cancer Epidemiol. Biomarkers Prev. 24 (2015), 773–782.
-
(2015)
Cancer Epidemiol. Biomarkers Prev.
, vol.24
, pp. 773-782
-
-
Rozemeijer, K.1
de Kok, I.M.2
Naber, S.K.3
-
5
-
-
84923624262
-
Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
-
Giorgi-Rossi, P., Fortunato, C., Barbarino, P., et al. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br. J. Cancer 29:January (112) (2015), 667–675.
-
(2015)
Br. J. Cancer
, vol.29
, Issue.January (112)
, pp. 667-675
-
-
Giorgi-Rossi, P.1
Fortunato, C.2
Barbarino, P.3
-
6
-
-
85013910502
-
Human papillomavirus self-sampling for screening non-attenders: opt-in pilot implementation with electronic communication platforms
-
Lam, J.U., Rebolj, M., Ejegod, D.M., et al. Human papillomavirus self-sampling for screening non-attenders: opt-in pilot implementation with electronic communication platforms. Int. J. Cancer 13:February (140) (2017), 2212–2219.
-
(2017)
Int. J. Cancer
, vol.13
, Issue.February (140)
, pp. 2212-2219
-
-
Lam, J.U.1
Rebolj, M.2
Ejegod, D.M.3
-
7
-
-
78751541434
-
The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)
-
Giorgi-Rossi, P., Marsili, L.M., Camilloni, L., et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br. J. Cancer 104 (2011), 248–254.
-
(2011)
Br. J. Cancer
, vol.104
, pp. 248-254
-
-
Giorgi-Rossi, P.1
Marsili, L.M.2
Camilloni, L.3
-
8
-
-
85040372838
-
High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
-
Lam, J.U.H., Elfstrom, K.M., Ejegod, D.M., et al. High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders. Br. J. Cancer 118 (2018), 138–144.
-
(2018)
Br. J. Cancer
, vol.118
, pp. 138-144
-
-
Lam, J.U.H.1
Elfstrom, K.M.2
Ejegod, D.M.3
-
9
-
-
85012993571
-
Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina
-
Arrossi, S., Paolino, M., Thouyaret, L., Laudi, R., Campanera, A., Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina. Implement. Sci., 13(February (12)), 2017, 17.
-
(2017)
Implement. Sci.
, vol.13
, Issue.February (12)
, pp. 17
-
-
Arrossi, S.1
Paolino, M.2
Thouyaret, L.3
Laudi, R.4
Campanera, A.5
-
10
-
-
85039432911
-
Safety and acceptability of human papillomavirus testing of self-collected specimens: a methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions
-
Leinonen, M.K., Schee, K., Jonassen, C.M., et al. Safety and acceptability of human papillomavirus testing of self-collected specimens: a methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions. J. Clin. Virol. 99 (2018), 22–30.
-
(2018)
J. Clin. Virol.
, vol.99
, pp. 22-30
-
-
Leinonen, M.K.1
Schee, K.2
Jonassen, C.M.3
-
11
-
-
85047257460
-
Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
-
Ejegod, D.M., Pedersen, H., Alzua, G.P., Pedersen, C., Bonde, J., Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening. Papillomavirus Res. 21:April (5) (2018), 192–200.
-
(2018)
Papillomavirus Res.
, vol.21
, Issue.April (5)
, pp. 192-200
-
-
Ejegod, D.M.1
Pedersen, H.2
Alzua, G.P.3
Pedersen, C.4
Bonde, J.5
-
12
-
-
84876558188
-
Evidence regarding HPV testing in secondary prevention of cervical cancer
-
Arbyn, M., Ronco, G., Anttila, A., et al. Evidence regarding HPV testing in secondary prevention of cervical cancer. Vaccine 30:Suppl. 5 (2012), F88–F99.
-
(2012)
Vaccine
, vol.30
, pp. F88-F99
-
-
Arbyn, M.1
Ronco, G.2
Anttila, A.3
-
13
-
-
58149292268
-
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
-
CJLM, Meijer, Castle, P.E., Hesselink, A.T., et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int. J. Cancer 124 (2009), 516–520.
-
(2009)
Int. J. Cancer
, vol.124
, pp. 516-520
-
-
CJLM, M.1
Castle, P.E.2
Hesselink, A.T.3
-
14
-
-
84940614795
-
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
-
Arbyn, M., Snijders, P.J., CJLM, Meijer, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?. Clin. Microbiol. Infect. 30:April (21) (2015), 817–826.
-
(2015)
Clin. Microbiol. Infect.
, vol.30
, Issue.April (21)
, pp. 817-826
-
-
Arbyn, M.1
Snijders, P.J.2
CJLM, M.3
-
15
-
-
84892951510
-
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
-
Arbyn, M., Verdoodt, F., Snijders, P.J.F., et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 15 (2014), 172–183.
-
(2014)
Lancet Oncol.
, vol.15
, pp. 172-183
-
-
Arbyn, M.1
Verdoodt, F.2
Snijders, P.J.F.3
-
16
-
-
84938590267
-
Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program
-
Arbyn, M., Castle, P., Offering self-sampling kits for HPV testing to reach women who do not attend in the regular cervical cancer screening program. Cancer Epidemiol. Biomarkers Prev. 24 (2015), 769–772.
-
(2015)
Cancer Epidemiol. Biomarkers Prev.
, vol.24
, pp. 769-772
-
-
Arbyn, M.1
Castle, P.2
-
17
-
-
0034609418
-
Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade sqaumous intraepethelial lesions
-
Sellors, J.W., Lorincz, A.T., Mahony, J.B., et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade sqaumous intraepethelial lesions. CMAJ 163 (2000), 513–518.
-
(2000)
CMAJ
, vol.163
, pp. 513-518
-
-
Sellors, J.W.1
Lorincz, A.T.2
Mahony, J.B.3
-
18
-
-
84907198227
-
Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis
-
Pathak, N., Dodds, J., Zamora, J., Khan, K., Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ, 349, 2014, g5264.
-
(2014)
BMJ
, vol.349
, pp. g5264
-
-
Pathak, N.1
Dodds, J.2
Zamora, J.3
Khan, K.4
-
19
-
-
84891538272
-
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic
-
Sahasrabuddhe, V.V., Gravitt, P.E., Dunn, S.T., et al. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J. Clin. Microbiol. 52:January (2014), 187–192.
-
(2014)
J. Clin. Microbiol.
, vol.52
, Issue.January
, pp. 187-192
-
-
Sahasrabuddhe, V.V.1
Gravitt, P.E.2
Dunn, S.T.3
-
20
-
-
84933182774
-
Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment
-
Stanczuk, G.A., Currie, H., Baxter, G., et al. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment. J. Clin. Pathol. 15:April (68) (2015), 567–570.
-
(2015)
J. Clin. Pathol.
, vol.15
, Issue.April (68)
, pp. 567-570
-
-
Stanczuk, G.A.1
Currie, H.2
Baxter, G.3
-
21
-
-
84951845016
-
Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer
-
Senkomago, V., Des Marais, A.C., Rahangdale, L., Vibat, C.R., Erlander, M.G., Smith, J.S., Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer. J. Clin. Virol. 74:January (2016), 26–31.
-
(2016)
J. Clin. Virol.
, vol.74
, Issue.January
, pp. 26-31
-
-
Senkomago, V.1
Des Marais, A.C.2
Rahangdale, L.3
Vibat, C.R.4
Erlander, M.G.5
Smith, J.S.6
-
22
-
-
84911002863
-
Optimization of HPV DNA detection in urine by improving collection, storage, and extraction
-
Vorsters, A., Van den Bergh, J., Micalessi, I., et al. Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur. J. Clin. Microbiol. Infect. Dis. 33:November (2014), 2005–2014.
-
(2014)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.33
, Issue.November
, pp. 2005-2014
-
-
Vorsters, A.1
Van den Bergh, J.2
Micalessi, I.3
-
23
-
-
85021702231
-
First-void urine: a potential biomarker source for triage of high-risk human papillomavirus infected women
-
Van Keer, S., Pattyn, J., Tjalma, W.A.A., et al. First-void urine: a potential biomarker source for triage of high-risk human papillomavirus infected women. Eur. J. Obstet. Gynecol. Reprod. Biol. 27:June (216) (2017), 1–11.
-
(2017)
Eur. J. Obstet. Gynecol. Reprod. Biol.
, vol.27
, Issue.June (216)
, pp. 1-11
-
-
Van Keer, S.1
Pattyn, J.2
Tjalma, W.A.A.3
-
24
-
-
85024844601
-
HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable to a physician-taken smear or brush-based self-sample: cross-sectional data from a triage population
-
Leeman, A., del PM, Molijn A., et al. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable to a physician-taken smear or brush-based self-sample: cross-sectional data from a triage population. BJOG 9:April (124) (2017), 1356–1363.
-
(2017)
BJOG
, vol.9
, Issue.April (124)
, pp. 1356-1363
-
-
Leeman, A.1
del PM, M.A.2
-
25
-
-
85022321791
-
Performance and diagnostic accuracy of a urine-based human papillomavirus assay in a referral population
-
Cuzick, J., Cadman, L., Ahmad, A.S., et al. Performance and diagnostic accuracy of a urine-based human papillomavirus assay in a referral population. Cancer Epidemiol Biomarkers Prev 21:February (26) (2017), 1053–1059.
-
(2017)
Cancer Epidemiol Biomarkers Prev
, vol.21
, Issue.February (26)
, pp. 1053-1059
-
-
Cuzick, J.1
Cadman, L.2
Ahmad, A.S.3
-
26
-
-
0037417585
-
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
-
Bossuyt, P.M., Reitsma, J.B., Bruns, D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 4:January (326) (2003), 41–44.
-
(2003)
BMJ
, vol.4
, Issue.January (326)
, pp. 41-44
-
-
Bossuyt, P.M.1
Reitsma, J.B.2
Bruns, D.E.3
-
27
-
-
0036966002
-
Sample size determination for establishing equivalence/noninferiority via ratio of two proportions in matched-pair design
-
Tang, M.L., Tang, N.S., Chan, I.S., Chan, B.P., Sample size determination for establishing equivalence/noninferiority via ratio of two proportions in matched-pair design. Biometrics 58:December (2002), 957–963.
-
(2002)
Biometrics
, vol.58
, Issue.December
, pp. 957-963
-
-
Tang, M.L.1
Tang, N.S.2
Chan, I.S.3
Chan, B.P.4
-
28
-
-
84978249321
-
Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections
-
Jentschke, M., Chen, K., Arbyn, M., et al. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J. Clin. Virol. 28:June (82) (2016), 46–50.
-
(2016)
J. Clin. Virol.
, vol.28
, Issue.June (82)
, pp. 46-50
-
-
Jentschke, M.1
Chen, K.2
Arbyn, M.3
-
29
-
-
34250681667
-
European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
-
Arbyn, M., Herbert, A., Schenck, U., et al. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 18 (2007), 133–139.
-
(2007)
Cytopathology
, vol.18
, pp. 133-139
-
-
Arbyn, M.1
Herbert, A.2
Schenck, U.3
-
30
-
-
79953837321
-
Comparison of clinical performance of abbott RealTime high risk HPV test with that of hybrid capture 2 assay in a screening setting
-
Carozzi, F.M., Burroni, E., Bisanzi, S., et al. Comparison of clinical performance of abbott RealTime high risk HPV test with that of hybrid capture 2 assay in a screening setting. J. Clin. Microbiol. 49:April (2011), 1446–1451.
-
(2011)
J. Clin. Microbiol.
, vol.49
, Issue.April
, pp. 1446-1451
-
-
Carozzi, F.M.1
Burroni, E.2
Bisanzi, S.3
-
31
-
-
79955529879
-
Comparison of clinical and analytical performance of the Abbott Real Time high risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening
-
Poljak, M., Ostrbenk, A., Seme, K., et al. Comparison of clinical and analytical performance of the Abbott Real Time high risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening. J. Clin. Microbiol. 49:May (2011), 1721–1729.
-
(2011)
J. Clin. Microbiol.
, vol.49
, Issue.May
, pp. 1721-1729
-
-
Poljak, M.1
Ostrbenk, A.2
Seme, K.3
-
32
-
-
84879456680
-
Clinical validation of the Abbott RealTime High Risk (HR) HPV assay according to the guidelines for HPV DNA test requirements for cervical screening
-
Hesselink, A.T., CJLM, Meijer, Poljak, M., et al. Clinical validation of the Abbott RealTime High Risk (HR) HPV assay according to the guidelines for HPV DNA test requirements for cervical screening. J. Clin. Microbiol. 51:May (1) (2013), 2409–2410.
-
(2013)
J. Clin. Microbiol.
, vol.51
, Issue.May (1)
, pp. 2409-2410
-
-
Hesselink, A.T.1
CJLM, M.2
Poljak, M.3
-
33
-
-
80355137211
-
Clinical validation of the cobas(R)4800 HPV test for cervical screening purposes
-
Heideman, D.A., Hesselink, A.T., Berkhof, J., et al. Clinical validation of the cobas(R)4800 HPV test for cervical screening purposes. J. Clin. Microbiol. 31:August (49) (2011), 3983–3985.
-
(2011)
J. Clin. Microbiol.
, vol.31
, Issue.August (49)
, pp. 3983-3985
-
-
Heideman, D.A.1
Hesselink, A.T.2
Berkhof, J.3
-
34
-
-
84874638820
-
HPV testing by cobas HPV test in a population from Catalonia
-
Lloveras, B., Gomez, S., Alameda, F., et al. HPV testing by cobas HPV test in a population from Catalonia. PLoS One, 8, 2013, e58153.
-
(2013)
PLoS One
, vol.8
, pp. e58153
-
-
Lloveras, B.1
Gomez, S.2
Alameda, F.3
-
35
-
-
84869213311
-
Clinical validation of a type-specific real time quantitative human papillomavirus PCR to the performance of hybrid capture 2 for the purpose of cervical cancer screening
-
Depuydt, C.E., Benoy, I.H., Beert, J.F., Criel, A.M., Bogers, J.J., Arbyn, M., Clinical validation of a type-specific real time quantitative human papillomavirus PCR to the performance of hybrid capture 2 for the purpose of cervical cancer screening. J. Clin. Microbiol. 10:October (50) (2012), 4073–4077.
-
(2012)
J. Clin. Microbiol.
, vol.10
, Issue.October (50)
, pp. 4073-4077
-
-
Depuydt, C.E.1
Benoy, I.H.2
Beert, J.F.3
Criel, A.M.4
Bogers, J.J.5
Arbyn, M.6
-
36
-
-
84960460457
-
VALGENT: a protocol for clinical validation of human papillomavirus assays
-
Arbyn, M., Depuydt, C., Benoy, I., et al. VALGENT: a protocol for clinical validation of human papillomavirus assays. J. Clin. Virol. 76:Suppl. 1 (2016), S14–S21.
-
(2016)
J. Clin. Virol.
, vol.76
, pp. S14-S21
-
-
Arbyn, M.1
Depuydt, C.2
Benoy, I.3
-
37
-
-
84908333136
-
Clinical validation of the BD onclarity™ HPV assay using a non-inferiority test
-
Ejegod, D.M., Serrano, I., Cuschieri, K., et al. Clinical validation of the BD onclarity™ HPV assay using a non-inferiority test. J. Med. Microbiol. Diagn. S3:003 (2014), 1–4.
-
(2014)
J. Med. Microbiol. Diagn.
, vol.S3003
, pp. 1-4
-
-
Ejegod, D.M.1
Serrano, I.2
Cuschieri, K.3
-
38
-
-
84983666603
-
Performance of a cartridge based assay for the detection of clinically significant HPV infection - lessons from VALGENT (Validation of HPV Genotyping Tests)
-
Cuschieri, K., Geraets, D., Cuzick, J., et al. Performance of a cartridge based assay for the detection of clinically significant HPV infection - lessons from VALGENT (Validation of HPV Genotyping Tests). J. Clin. Microbiol. 6:July (54) (2016), 2337–2347.
-
(2016)
J. Clin. Microbiol.
, vol.6
, Issue.July (54)
, pp. 2337-2347
-
-
Cuschieri, K.1
Geraets, D.2
Cuzick, J.3
-
39
-
-
84958157507
-
Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening
-
Hesselink, A.T., Sahli, R., Berkhof, J., et al. Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening. J. Clin. Virol. 15:January (76) (2016), 36–39.
-
(2016)
J. Clin. Virol.
, vol.15
, Issue.January (76)
, pp. 36-39
-
-
Hesselink, A.T.1
Sahli, R.2
Berkhof, J.3
-
40
-
-
84959503498
-
Clinical validation of anyplex II HPV HR detection test for cervical cancer screening in Korea
-
Jung, S., Lee, B., Lee, K.N., Kim, Y., Oh, E.J., Clinical validation of anyplex II HPV HR detection test for cervical cancer screening in Korea. Arch. Pathol. Lab. Med. 140:March (2016), 276–280.
-
(2016)
Arch. Pathol. Lab. Med.
, vol.140
, Issue.March
, pp. 276-280
-
-
Jung, S.1
Lee, B.2
Lee, K.N.3
Kim, Y.4
Oh, E.J.5
-
41
-
-
70350738496
-
How to evaluate emerging technologies in cervical cancer screening?
-
Arbyn, M., Ronco, G., Cuzick, J., Wentzensen, N., Castle, P.E., How to evaluate emerging technologies in cervical cancer screening?. Int. J. Cancer 125 (2009), 2489–2496.
-
(2009)
Int. J. Cancer
, vol.125
, pp. 2489-2496
-
-
Arbyn, M.1
Ronco, G.2
Cuzick, J.3
Wentzensen, N.4
Castle, P.E.5
-
42
-
-
0742318857
-
Sources of variation and bias in studies of diagnostic accuracy: a systematic review
-
Whiting, P., Rutjes, A.W., Reitsma, J.B., Glas, A.S., Bossuyt, P.M., Kleijnen, J., Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann. Intern. Med. 3:February (140) (2004), 189–202.
-
(2004)
Ann. Intern. Med.
, vol.3
, Issue.February (140)
, pp. 189-202
-
-
Whiting, P.1
Rutjes, A.W.2
Reitsma, J.B.3
Glas, A.S.4
Bossuyt, P.M.5
Kleijnen, J.6
-
43
-
-
0020728415
-
Assessment of diagnostic tests when disease verification is subject to selection bias
-
Begg, C.B., Greenes, R.A., Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 39 (1983), 207–215.
-
(1983)
Biometrics
, vol.39
, pp. 207-215
-
-
Begg, C.B.1
Greenes, R.A.2
-
44
-
-
0028033920
-
Efficient study designs to assess the accuracy of screening tests
-
Irwig, L., Glasziou, P.P., Berry, G., Chock, C., Mock, P., Simpson, J.M., Efficient study designs to assess the accuracy of screening tests. Am. J. Epidemiol. 140 (1994), 759–769.
-
(1994)
Am. J. Epidemiol.
, vol.140
, pp. 759-769
-
-
Irwig, L.1
Glasziou, P.P.2
Berry, G.3
Chock, C.4
Mock, P.5
Simpson, J.M.6
-
45
-
-
0023125776
-
Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer
-
Schatzkin, A., Connor, R.J., Taylor, P.R., Bunnag, B., Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am. J. Epidemiol. 125 (1987), 672–678.
-
(1987)
Am. J. Epidemiol.
, vol.125
, pp. 672-678
-
-
Schatzkin, A.1
Connor, R.J.2
Taylor, P.R.3
Bunnag, B.4
-
46
-
-
0034660422
-
Assessing the relative accuracies of two screening tests in the presence of verification bias
-
Zhou, X.H., Higgs, R.E., Assessing the relative accuracies of two screening tests in the presence of verification bias. Stat. Med. 15:June (19) (2000), 1697–1705.
-
(2000)
Stat. Med.
, vol.15
, Issue.June (19)
, pp. 1697-1705
-
-
Zhou, X.H.1
Higgs, R.E.2
-
47
-
-
84960468575
-
Triage of HPV positive women in cervical cancer screening
-
Wentzensen, N., Schiffman, M., Palmer, T., Arbyn, M., Triage of HPV positive women in cervical cancer screening. J. Clin. Virol. 76 (2016), S49–S55.
-
(2016)
J. Clin. Virol.
, vol.76
, pp. S49-S55
-
-
Wentzensen, N.1
Schiffman, M.2
Palmer, T.3
Arbyn, M.4
-
48
-
-
0043198760
-
Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus
-
Garcia, F., Barker, B., Santos, C., et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet. Gynecol. 102 (2003), 266–272.
-
(2003)
Obstet. Gynecol.
, vol.102
, pp. 266-272
-
-
Garcia, F.1
Barker, B.2
Santos, C.3
-
49
-
-
0036270229
-
Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women
-
Nobbenhuis, M.A., Helmerhorst, T.J., van den Brule, A.J., et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J. Clin. Pathol. 55:June (2002), 435–439.
-
(2002)
J. Clin. Pathol.
, vol.55
, Issue.June
, pp. 435-439
-
-
Nobbenhuis, M.A.1
Helmerhorst, T.J.2
van den Brule, A.J.3
-
50
-
-
33746216129
-
High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush
-
Brink, A.A., CJLM, Meijer, Wiegerinck, M.A., et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J. Clin. Microbiol. 44:July (2006), 2518–2523.
-
(2006)
J. Clin. Microbiol.
, vol.44
, Issue.July
, pp. 2518-2523
-
-
Brink, A.A.1
CJLM, M.2
Wiegerinck, M.A.3
-
51
-
-
84869881661
-
Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape
-
551-*
-
Snellenberg, S., De Strooper, L.M., Hesselink, A.T., et al. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer, 12, 2012 551-*.
-
(2012)
BMC Cancer
, vol.12
-
-
Snellenberg, S.1
De Strooper, L.M.2
Hesselink, A.T.3
-
52
-
-
84870170478
-
Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3
-
Wentzensen, N., Sun, C., Ghosh, A., et al. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J. Natl. Cancer Inst., 23(October), 2012.
-
(2012)
J. Natl. Cancer Inst.
, vol.23
, Issue.October
-
-
Wentzensen, N.1
Sun, C.2
Ghosh, A.3
-
53
-
-
85052900590
-
Kan de dekkingsgraad voor screening van baarmoederhalskanker verhoogd worden door gebruik te maken van een thuistest voor screening: een pilootstudie in een huisartsenpraktijk?
-
Vrije Universiteit Brussel
-
Cornet, K., Kan de dekkingsgraad voor screening van baarmoederhalskanker verhoogd worden door gebruik te maken van een thuistest voor screening: een pilootstudie in een huisartsenpraktijk?. 2015, Vrije Universiteit Brussel.
-
(2015)
-
-
Cornet, K.1
-
54
-
-
85015964385
-
Offering self-sampling to cervical screening non-attenders in primary care
-
Lim, A.W., Hollingworth, A., Kalwij, S., Curran, G., Sasieni, P., Offering self-sampling to cervical screening non-attenders in primary care. J. Med. Screen. 24 (2017), 43–49.
-
(2017)
J. Med. Screen.
, vol.24
, pp. 43-49
-
-
Lim, A.W.1
Hollingworth, A.2
Kalwij, S.3
Curran, G.4
Sasieni, P.5
|